Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma and Salivary Gland Tumors
NCT00095563Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2004
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in adenoid cystic carcinoma (ACC), salivary gland cancer (SGC), sponsored by National Cancer Institute. Started Sep 2004; status: completed.
02
Drugs
lapatinib
03
Conditions
adenoid cystic carcinoma (ACC)salivary gland cancer (SGC)
Beyond the preview
Go deeper on NCT00095563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095563.